Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.ctrv.2017.03.010 http://scihub22266oqcxt.onion/10.1016/j.ctrv.2017.03.010 C5604432!5604432!28431262     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Cancer+Treat+Rev 2017 ; 55 (ä): 190-9 Nephropedia Template TP {{tp|p=28431262|t=2017. Immunologic Approaches for the Treatment of Multiple Myeloma |pdf=|usr=}}{{28431262}} gab.com Text Immunologic Approaches for the Treatment of Multiple Myeloma JO: Cancer Treat Rev http://www.kidney.de/pget.php?&tw=1&pmid=28431262 #FOAvip The FDA approval of two monoclonal antibodies in 2015 has heralded a new era of targeted immunotherapies for multiple myeloma (MM). In this review we discuss the recent approaches using different immunological components to treat MM. In particular, we review current monoclonal antibody based therapies, engineered T- and NK cell products, ?off-target? immunomodulation, and strategies utilizing allogeneic cell transplantation in MM. We discuss how an immunologic approach offers promise for the treatment of this genetically heterogeneous disease, and how patients with acquired drug resistance may particularly benefit from these therapies. We also describe some of the limitations of the current strategies and speculate on the future of personalized immunotherapies for MM. Twit Text FOAVip Immunologic Approaches for the Treatment of Multiple Myeloma ????Cancer Treat Rev http://www.kidney.de/pget.php?&tw=1&pmid=28431262 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28431262 #FOAvip English Wikipedia <ref>{{Cite pmid|28431262}}</ref> Immunologic Approaches for the Treatment of Multiple Myeloma #MMPMID28431262 Rasche L; Weinhold N; Morgan GJ; van Rhee F; Davies FE Cancer Treat Rev 2017[Apr]; 55 (ä): 190-9 PMID28431262show ga The FDA approval of two monoclonal antibodies in 2015 has heralded a new era of targeted immunotherapies for multiple myeloma (MM). In this review we discuss the recent approaches using different immunological components to treat MM. In particular, we review current monoclonal antibody based therapies, engineered T- and NK cell products, ?off-target? immunomodulation, and strategies utilizing allogeneic cell transplantation in MM. We discuss how an immunologic approach offers promise for the treatment of this genetically heterogeneous disease, and how patients with acquired drug resistance may particularly benefit from these therapies. We also describe some of the limitations of the current strategies and speculate on the future of personalized immunotherapies for MM. äImmunologic Approaches for the Treatment of Multiple Myeloma (epmc).pdf DeepDyve Pubget Overpricing